Unknown

Dataset Information

0

Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort.


ABSTRACT: The tumor proliferation index marker Ki-67 is strongly associated with tumor cell proliferation, growth and progression, and is widely used in routine clinicopathological investigation. Prostate cancer is a complex multifaceted and biologically heterogeneous disease, and overtreatment of localized, low volume indolent tumors, is evident. Here, we aimed to assess Ki-67 expression and related outcomes of 535 patients treated with radical prostatectomy. The percentage of tumor epithelial cells expressing Ki-67 was determined by immunohistochemical assay, both digital image analysis and visual scoring by light microscope were used for quantification. The association of Ki-67 and prostate cancer was evaluated, as well as its prognostic value. There was a positive correlation between high expression of Ki-67 and Gleason score > 7 (p < 0.001) as well as tumor size (? 20 mm, p = 0.03). In univariate analyses, a high expression of Ki-67 in tumor epithelium was significantly associated with biochemical failure (BF) (digital scoring, p = 0.014) and (visual scoring, p = 0.004). In the multivariate analyses, a high level of Ki-67 was an independent poor prognostic factor for biochemical failure-free survival (BFFS) (Visual scoring, Ki67, p = 0.012, HR:1.50, CI95% 1.10-2.06). In conclusion, high Ki-67 expression is an independent negative prognostic marker for biochemical failure. Our findings support the role of Ki-67 as a significant, poor prognostic factor for in prostate cancer outcome.

SUBMITTER: Richardsen E 

PROVIDER: S-EPMC5687762 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

altmetric image

Publications


The tumor proliferation index marker Ki-67 is strongly associated with tumor cell proliferation, growth and progression, and is widely used in routine clinicopathological investigation. Prostate cancer is a complex multifaceted and biologically heterogeneous disease, and overtreatment of localized, low volume indolent tumors, is evident. Here, we aimed to assess Ki-67 expression and related outcomes of 535 patients treated with radical prostatectomy. The percentage of tumor epithelial cells expr  ...[more]

Similar Datasets

| S-EPMC8628729 | biostudies-literature
| S-EPMC5994254 | biostudies-other
| S-EPMC4841783 | biostudies-literature
2018-10-26 | PXD003551 | Pride
| S-EPMC5173108 | biostudies-literature
| S-EPMC8629999 | biostudies-literature
| S-EPMC4783103 | biostudies-literature
| S-EPMC4868756 | biostudies-literature
| S-EPMC5468356 | biostudies-literature
| S-EPMC6515572 | biostudies-literature